An NMR metabolomics method employing a selective isotope-labeling strategy is presented to study metabolic crosstalk in routine cell cultures, and can be easily adapted to a variety of cellular crosstalk systems, such as neuron-astrocyte, host-pathogen, or host-microbiota systems.
Abstract
Metabolic crosstalk between cell types is critical to our mechanistic understanding of pancreatic cancer. The lack of methods to investigate metabolic crosstalk has impeded the comprehensive OMIC characterization of these complex cellular systems. To address this need, an NMR metabolomics method employing a selective isotope-labeling strategy is presented to study metabolic crosstalk in routine cell cultures. 2D 1H-13C HSQC NMR experiments were used to simultaneously monitor pancreatic cancer cells and stromal cells, which revealed a cancer-cell-induced metabolic remodeling of stromal cells. Cancer-cell-conditioned medium was used to stimulate stromal cells, which identified a unique and divergent metabolism in stromal cells in contrast to the classical Warburg metabolism in cancer cells. The two phenotypically different stromal cells exhibited distinct stimulated metabolic profiles; however, the exo-metabolome from both stimulated stromal cells revealed that 13C6-glucose-derived carbon is excreted as alanine and pyruvate. Furthermore, intracellular 13C6-glucose was converted to a variety of tricarboxylic acid cycle-linked and redox metabolites. Stromal cells, unlike cancer cells, mainly convert 13C3-pyruvate to alanine and lactate at an early growth time point, followed by the incorporation of 13C3-pyruvate-derived carbon into multiple amino acids. Interestingly, unstimulated stromal cells depend on pyruvate for survival, whereas cancer cells do not. Simply put, efficient metabolic crosstalk between cancer and stromal cells enables the cells to utilize different metabolic pathways and nutrient sources. Although presented to study cancer-stromal crosstalk, the method can be easily adapted to a variety of cellular crosstalk systems, such as neuron-astrocyte, host-pathogen, or host-microbiota systems.
Pancreatic ductal adenocarcinoma (PDAC) is characterized by a nutrient-poor, hypoxic, and highly desmoplastic microenvironment that imposes substantial metabolic stress on malignant cells. Under these unfavorable conditions, lipid metabolism reprogramming provides cancer cells with the flexibility needed to maintain gr...
Xing-Yu Liu, Zi-Tong Ye, L. Wang et al.· Frontiers in Oncology· 0 citations
Background: Cancer is characterized not only by genetic and epigenetic abnormalities but also by profound alterations in cellular metabolism. Metabolic reprogramming enables malignant cells to meet the increased requirements for energy production, biosynthesis, redox regulation, proliferation, invasion, and adaptation...
Arshiya Fatima, Mohammed Abdul Muqeeth, K. Maanasa et al.· International Journal of Med...· 0 citations
Metabolic pathways in tumor cells can diverge significantly from the canonical pathways described for healthy tissues and cells. Although they involve the same proteins and substrate molecules, differences in metabolite concentrations, the skipping of only a few pathway participants, and alterations in downstream signa...
R. Mikheeva, P. Leonov, M. Koryukov et al.· DNA Repair· 0 citations
BACKGROUND
Diabetes is a known risk factor, and a distinct form termed pancreatic cancer-related diabetes (PCRD) often precedes the diagnosis of cancer by 3-5 years, offering a potential window for intervention. We hypothesised that interactions between stromal pancreatic stellate cells (PSCs) and cancer cells trigger...
Rohit Sarkar, C. Perera, M. J. Hossain et al.· Pancreatology : official jou...· 0 citations
In summary, in-depth elucidation of the molecular mechanisms underlying macrophage metabolic reprogramming and their metabolic crosstalk with breast cancer cells will provide new insights and novel therapeutic targets for the precise immunometabolic therapy of breast cancer.
Jiao-Yu Zhang, Rui Yang· Cancer Treatment and Researc...· 0 citations
Gastric cancer is driven by aberrant kinase signaling that promotes uncontrolled proliferation and metabolic adaptations. Although calcium/calmodulin-dependent protein kinase 2 (CAMKK2) is overexpressed in gastric cancer, its role in regulating tumor-associated metabolic programs remains unclear. Here, we employed an i...
M. A. Najar, Nikita Choudhary, Nidhi Dwivedi et al.· Journal of Proteome Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.